{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:20:00Z","timestamp":1789579200182,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J01563"],"award-info":[{"award-number":["2023J01563"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22665-0","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:29:35Z","timestamp":1762435775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the mechanism of PFTrDA on human hepatic metabolic diseases based on network toxicology and molecular docking"],"prefix":"10.1038","volume":"15","author":[{"given":"Zengqiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"22665_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. & Rinella, M. Non-alcoholic fatty liver disease. Lancet (London England) 397, 2212\u20132224. https:\/\/doi.org\/10.1016\/s0140-6736(20)32511-3 (2021).","journal-title":"Lancet (London England)"},{"key":"22665_CR2","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1007\/s11356-017-0872-7","volume":"25","author":"X Wu","year":"2018","unstructured":"Wu, X., Xie, G., Xu, X., Wu, W. & Yang, B. Adverse bioeffect of perfluorooctanoic acid on liver metabolic function in mice. Environ. Sci. Pollut. Res. Int. 25, 4787\u20134793. https:\/\/doi.org\/10.1007\/s11356-017-0872-7 (2018).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"22665_CR3","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song, S. J., Lai, J. C., Wong, G. L., Wong, V. W. & Yip, T. C. Can we use old NAFLD data under the new MASLD definition?. J. Hepatol. 80, e54\u2013e56. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.021 (2024).","journal-title":"J. Hepatol."},{"key":"22665_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861. https:\/\/doi.org\/10.1016\/s2468-1253(22)00165-0 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"22665_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol. (Baltimore Md.) 64, 73\u201384. https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatol. (Baltimore Md.)"},{"key":"22665_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113\u2013121. https:\/\/doi.org\/10.1053\/j.gastro.2005.04.014 (2005).","journal-title":"Gastroenterology"},{"key":"22665_CR7","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe, R. F., Tabas, I. & Pajvani, U. B. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158, 1913\u20131928. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.311 (2020).","journal-title":"Gastroenterology"},{"key":"22665_CR8","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/ijc.25797","volume":"128","author":"J Ertle","year":"2011","unstructured":"Ertle, J. et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int. J. Cancer 128, 2436\u20132443. https:\/\/doi.org\/10.1002\/ijc.25797 (2011).","journal-title":"Int. J. Cancer"},{"key":"22665_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","volume":"22","author":"V Manne","year":"2018","unstructured":"Manne, V., Handa, P. & Kowdley, K. V. Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Clin. Liver Dis. 22, 23\u201337. https:\/\/doi.org\/10.1016\/j.cld.2017.08.007 (2018).","journal-title":"Clin. Liver Dis."},{"issue":"1567\u20131576","key":"22665_CR10","doi-asserted-by":"publisher","first-page":"1576.e1561","DOI":"10.1053\/j.gastro.2010.07.057","volume":"139","author":"N Chalasani","year":"2010","unstructured":"Chalasani, N. et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 139(1567\u20131576), 1576.e1561\u20131566. https:\/\/doi.org\/10.1053\/j.gastro.2010.07.057 (2010).","journal-title":"Gastroenterology"},{"key":"22665_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","volume":"10","author":"A Wree","year":"2013","unstructured":"Wree, A., Broderick, L., Canbay, A., Hoffman, H. M. & Feldstein, A. E. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. 10, 627\u2013636. https:\/\/doi.org\/10.1038\/nrgastro.2013.149 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"22665_CR12","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metab. Clin. Exp. 65, 1038\u20131048. https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012 (2016).","journal-title":"Metab. Clin. Exp."},{"key":"22665_CR13","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564. https:\/\/doi.org\/10.1016\/j.cell.2021.04.015 (2021).","journal-title":"Cell"},{"key":"22665_CR14","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatol. (Baltimore Md.) 52, 1836\u20131846. https:\/\/doi.org\/10.1002\/hep.24001 (2010).","journal-title":"Hepatol. (Baltimore Md.)"},{"key":"22665_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/10408444.2016.1182117","volume":"46","author":"CC Bach","year":"2016","unstructured":"Bach, C. C. et al. Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review. Crit. Rev. Toxicol. 46, 735\u2013755. https:\/\/doi.org\/10.1080\/10408444.2016.1182117 (2016).","journal-title":"Crit. Rev. Toxicol."},{"key":"22665_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15091880","author":"MS Petersen","year":"2018","unstructured":"Petersen, M. S. et al. Reproductive function in a population of young Faroese men with elevated exposure to polychlorinated biphenyls (PCBs) and perfluorinated alkylate substances (PFAS). Int. J. Environ. Res. Public Health https:\/\/doi.org\/10.3390\/ijerph15091880 (2018).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"22665_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41370-018-0109-y","volume":"29","author":"KE Boronow","year":"2019","unstructured":"Boronow, K. E. et al. Serum concentrations of PFASs and exposure-related behaviors in African American and non-Hispanic white women. J. Eposure Sci. Environ. Epidemiol. 29, 206\u2013217. https:\/\/doi.org\/10.1038\/s41370-018-0109-y (2019).","journal-title":"J. Eposure Sci. Environ. Epidemiol."},{"key":"22665_CR18","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.chemosphere.2011.09.024","volume":"85","author":"W Liu","year":"2011","unstructured":"Liu, W., Chen, S., Harada, K. H. & Koizumi, A. Analysis of perfluoroalkyl carboxylates in vacuum cleaner dust samples in Japan. Chemosphere 85, 1734\u20131741. https:\/\/doi.org\/10.1016\/j.chemosphere.2011.09.024 (2011).","journal-title":"Chemosphere"},{"key":"22665_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.marpolbul.2018.08.051","volume":"136","author":"Y Fujii","year":"2018","unstructured":"Fujii, Y. et al. Different profiles of naturally produced and anthropogenic organohalogens in the livers of cetaceans from the Sea of Japan and the North Pacific Ocean. Mar. Pollut. Bull. 136, 230\u2013242. https:\/\/doi.org\/10.1016\/j.marpolbul.2018.08.051 (2018).","journal-title":"Mar. Pollut. Bull."},{"key":"22665_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.envint.2013.07.013","volume":"60","author":"E Okada","year":"2013","unstructured":"Okada, E. et al. Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003\u20132011. Environ. Int. 60, 89\u201396. https:\/\/doi.org\/10.1016\/j.envint.2013.07.013 (2013).","journal-title":"Environ. Int."},{"key":"22665_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00204-014-1391-7","volume":"90","author":"N Sheng","year":"2016","unstructured":"Sheng, N., Li, J., Liu, H., Zhang, A. & Dai, J. Interaction of perfluoroalkyl acids with human liver fatty acid-binding protein. Arch. Toxicol. 90, 217\u2013227. https:\/\/doi.org\/10.1007\/s00204-014-1391-7 (2016).","journal-title":"Arch. Toxicol."},{"key":"22665_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrendo.2017.42","volume":"13","author":"CE Foulds","year":"2017","unstructured":"Foulds, C. E., Trevi\u00f1o, L. S., York, B. & Walker, C. L. Endocrine-disrupting chemicals and fatty liver disease. Nat. Rev. Endocrinol. 13, 445\u2013457. https:\/\/doi.org\/10.1038\/nrendo.2017.42 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"22665_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","volume":"68","author":"JJ Heindel","year":"2017","unstructured":"Heindel, J. J. et al. Metabolism disrupting chemicals and metabolic disorders. Reproduct. Toxicol. (Elmsford N. Y.) 68, 3\u201333. https:\/\/doi.org\/10.1016\/j.reprotox.2016.10.001 (2017).","journal-title":"Reproduct. Toxicol. (Elmsford N. Y.)"},{"key":"22665_CR24","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51, D1373-d1380. https:\/\/doi.org\/10.1093\/nar\/gkac956 (2023).","journal-title":"Nucleic Acids Res."},{"key":"22665_CR25","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton, A. et al. The ChEMBL database in 2017. Nucleic Acids Res. 45, D945-d954. https:\/\/doi.org\/10.1093\/nar\/gkw1074 (2017).","journal-title":"Nucleic Acids Res."},{"key":"22665_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.5","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinform. https:\/\/doi.org\/10.1002\/cpbi.5 (2016).","journal-title":"Curr. Protoc. Bioinform."},{"key":"22665_CR27","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607-d613. https:\/\/doi.org\/10.1093\/nar\/gky1131 (2019).","journal-title":"Nucleic Acids Res."},{"key":"22665_CR28","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303 (2003).","journal-title":"Genome Res."},{"key":"22665_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211 (2009).","journal-title":"Nat. Protoc."},{"key":"22665_CR30","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. Publ. Protein Soc. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"22665_CR31","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672-d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"22665_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jat.4506","volume":"44","author":"S Huang","year":"2024","unstructured":"Huang, S. A novel strategy for the study on molecular mechanism of prostate injury induced by 4,4\u2032-sulfonyldiphenol based on network toxicology analysis. J. Appl. Toxicol. JAT 44, 28\u201340. https:\/\/doi.org\/10.1002\/jat.4506 (2024).","journal-title":"J. Appl. Toxicol. JAT"},{"key":"22665_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10142-025-01616-y","volume":"25","author":"J Li","year":"2025","unstructured":"Li, J. et al. Analyzing the potential targets and mechanism of per- and polyfluoroalkyl substances (PFAS) on breast cancer by integrating network toxicology, single-cell sequencing, spatial transcriptomics, and molecular simulation. Funct. Integr. Genomics 25, 119. https:\/\/doi.org\/10.1007\/s10142-025-01616-y (2025).","journal-title":"Funct. Integr. Genomics"},{"key":"22665_CR34","doi-asserted-by":"publisher","first-page":"116251","DOI":"10.1016\/j.ecoenv.2024.116251","volume":"275","author":"X Xu","year":"2024","unstructured":"Xu, X. et al. Exploring the molecular mechanisms by which per- and polyfluoroalkyl substances induce polycystic ovary syndrome through in silico toxicogenomic data mining. Ecotoxicol. Environ. Saf. 275, 116251. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.116251 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"22665_CR35","doi-asserted-by":"publisher","first-page":"e37003","DOI":"10.1016\/j.heliyon.2024.e37003","volume":"10","author":"Z Lin","year":"2024","unstructured":"Lin, Z. et al. Exploring the environmental contamination toxicity and potential carcinogenic pathways of perfluorinated and polyfluoroalkyl substances (PFAS): An integrated network toxicology and molecular docking strategy. Heliyon 10, e37003. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37003 (2024).","journal-title":"Heliyon"},{"key":"22665_CR36","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.2337\/db14-0369","volume":"63","author":"KC Hames","year":"2014","unstructured":"Hames, K. C., Vella, A., Kemp, B. J. & Jensen, M. D. Free fatty acid uptake in humans with CD36 deficiency. Diabetes 63, 3606\u20133614. https:\/\/doi.org\/10.2337\/db14-0369 (2014).","journal-title":"Diabetes"},{"key":"22665_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2337\/db14-0582","volume":"64","author":"D Samovski","year":"2015","unstructured":"Samovski, D. et al. Regulation of AMPK activation by CD36 links fatty acid uptake to \u03b2-oxidation. Diabetes 64, 353\u2013359. https:\/\/doi.org\/10.2337\/db14-0582 (2015).","journal-title":"Diabetes"},{"key":"22665_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/eci.12192","volume":"44","author":"C Garc\u00eda-Monz\u00f3n","year":"2014","unstructured":"Garc\u00eda-Monz\u00f3n, C. et al. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. Eur. J. Clin. Invest. 44, 65\u201373. https:\/\/doi.org\/10.1111\/eci.12192 (2014).","journal-title":"Eur. J. Clin. Invest."},{"key":"22665_CR39","doi-asserted-by":"publisher","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","volume":"294","author":"D Greco","year":"2008","unstructured":"Greco, D. et al. Gene expression in human NAFLD. Am. J. Physiol. Gastroint. Liver Physiol. 294, G1281-1287. https:\/\/doi.org\/10.1152\/ajpgi.00074.2008 (2008).","journal-title":"Am. J. Physiol. Gastroint. Liver Physiol."},{"key":"22665_CR40","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.2337\/db07-0907","volume":"56","author":"DP Koonen","year":"2007","unstructured":"Koonen, D. P. et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 56, 2863\u20132871. https:\/\/doi.org\/10.2337\/db07-0907 (2007).","journal-title":"Diabetes"},{"key":"22665_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/en.2015-1866","volume":"157","author":"CG Wilson","year":"2016","unstructured":"Wilson, C. G. et al. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology 157, 570\u2013585. https:\/\/doi.org\/10.1210\/en.2015-1866 (2016).","journal-title":"Endocrinology"},{"key":"22665_CR42","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.2010.222844","volume":"60","author":"ME Miquilena-Colina","year":"2011","unstructured":"Miquilena-Colina, M. E. et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut 60, 1394\u20131402. https:\/\/doi.org\/10.1136\/gut.2010.222844 (2011).","journal-title":"Gut"},{"key":"22665_CR43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.exphem.2005.06.007","volume":"33","author":"T Evans","year":"2005","unstructured":"Evans, T. Regulation of hematopoiesis by retinoid signaling. Exp. Hematol. 33, 1055\u20131061. https:\/\/doi.org\/10.1016\/j.exphem.2005.06.007 (2005).","journal-title":"Exp. Hematol."},{"key":"22665_CR44","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1080\/1042819031000116661","volume":"44","author":"T Oren","year":"2003","unstructured":"Oren, T., Sher, J. A. & Evans, T. Hematopoiesis and retinoids: development and disease. Leuk. Lymphoma 44, 1881\u20131891. https:\/\/doi.org\/10.1080\/1042819031000116661 (2003).","journal-title":"Leuk. Lymphoma"},{"key":"22665_CR45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1530\/rep.1.00799","volume":"131","author":"L Cammas","year":"2006","unstructured":"Cammas, L. et al. Developmental regulation of prostacyclin synthase and prostacyclin receptors in the ovine uterus and conceptus during the peri-implantation period. Reproduction (Cambridge England) 131, 917\u2013927. https:\/\/doi.org\/10.1530\/rep.1.00799 (2006).","journal-title":"Reproduction (Cambridge England)"},{"key":"22665_CR46","doi-asserted-by":"publisher","first-page":"117042","DOI":"10.1016\/j.taap.2024.117042","volume":"490","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Liquidambaric acid inhibits the proliferation of hepatocellular carcinoma cells by targeting PPAR\u03b1-RXR\u03b1 to down-regulate fatty acid metabolism. Toxicol. Appl. Pharmacol. 490, 117042. https:\/\/doi.org\/10.1016\/j.taap.2024.117042 (2024).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"22665_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev.physiol.68.033104.152158","volume":"68","author":"NY Kalaany","year":"2006","unstructured":"Kalaany, N. Y. & Mangelsdorf, D. J. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68, 159\u2013191. https:\/\/doi.org\/10.1146\/annurev.physiol.68.033104.152158 (2006).","journal-title":"Annu. Rev. Physiol."},{"key":"22665_CR48","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","volume":"9","author":"PJ Willy","year":"1995","unstructured":"Willy, P. J. et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9, 1033\u20131045. https:\/\/doi.org\/10.1101\/gad.9.9.1033 (1995).","journal-title":"Genes Dev."},{"key":"22665_CR49","doi-asserted-by":"publisher","first-page":"e0224405","DOI":"10.1371\/journal.pone.0224405","volume":"14","author":"F Stossi","year":"2019","unstructured":"Stossi, F. et al. Tributyltin chloride (TBT) induces RXRA down-regulation and lipid accumulation in human liver cells. PLoS ONE 14, e0224405. https:\/\/doi.org\/10.1371\/journal.pone.0224405 (2019).","journal-title":"PLoS ONE"},{"key":"22665_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"22665_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 7, 6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"22665_CR52","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti, G. A., Machado, M. V. & Diehl, A. M. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656\u2013665. https:\/\/doi.org\/10.1038\/nrgastro.2013.183 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"22665_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123966","author":"P Dongiovanni","year":"2018","unstructured":"Dongiovanni, P., Meroni, M., Longo, M., Fargion, S. & Fracanzani, A. L. miRNA signature in NAFLD: A turning point for a non-invasive diagnosis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms19123966 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"22665_CR54","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Akinyemiju, T. et al. The burden of primary liver cancer and underlying Etiologies from 1990 to 2015 at the global, regional, and national level: Results from the global burden of disease study 2015. JAMA Oncol. 3, 1683\u20131691. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3055 (2017).","journal-title":"JAMA Oncol."},{"key":"22665_CR55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer 122, 4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z (2020).","journal-title":"Br. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22665-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22665-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22665-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:29:36Z","timestamp":1762435776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22665-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22665"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22665-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38872"}}